Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538732 | 0.98 | ALDH1A1 (0.65) | ALDH1A1TSHRKDM4EGAAMAPT | |
| Hydrazine SCHEMBL11456438 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TSHRKDM4EGAAMAPT | |
| SCHEMBL1935788 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TSHRKDM4EGAAMAPT | |
| SCHEMBL9441768 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TSHRKDM4EGAAMAPT | |
| SCHEMBL9066485 | 0.95 | TSHR (0.62) | ALDH1A1TSHRKDM4EGAAMAPT | |
| SCHEMBL16931576 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TSHRKDM4EGAAMAPT | |
| Methyl Alcohol SCHEMBL11821254 | 0.93 | TSHR (0.60) | ALDH1A1TSHRKDM4EGAAMAPT | |
| Methyl Alcohol SCHEMBL11819819 | 0.91 | TSHR (0.58) | ALDH1A1TSHRKDM4EGAAMAPT | |
| SCHEMBL290485 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL11667227 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1309578-B1 | METHOD FOR THE PRODUCTION OF A PARTICLE-CONTAINING PREPARATION OF TETRAHYDRO- 3,5-DIMETHYL-1,3,5-THIADIAZIN-2-THIONE | BASF AG (DE) | 2004-02-18 | — | — | EP | claimed |
| US-6693191-B2 | FORMING NARROW PARTICLE SIZE LOW FINE CONTENT MATERIAL; REACTING METHYLAMMONIUM N-METHYLDITHIOCARBAMATE AND FORMALDEHYDE IN AQUEOUS SOLUTION WHILE MAINTAINING CONSTANT CONCENTRATION RATIO | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-17 | — | — | US | claimed |
| US-20030176692-A1 | Combining aqueous methylammonium N-methyldithiocarbamate with formaldehyde, separating then drying | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-18 | — | — | US | claimed |
| US-6693191-B2 | FORMING NARROW PARTICLE SIZE LOW FINE CONTENT MATERIAL; REACTING METHYLAMMONIUM N-METHYLDITHIOCARBAMATE AND FORMALDEHYDE IN AQUEOUS SOLUTION WHILE MAINTAINING CONSTANT CONCENTRATION RATIO | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-17 | — | — | US | disclosed |
| US-20030176692-A1 | Combining aqueous methylammonium N-methyldithiocarbamate with formaldehyde, separating then drying | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176692-A1 | Combining aqueous methylammonium N-methyldithiocarbamate with formaldehyde, separating then drying | MTHFD2, DIMT1, TPMT | ALDH1A1 1946/4885TSHR 1261/4885KDM4E 1358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.